2547 studies found for:    hormone therapy AND (woman OR women OR female)
Show Display Options
Rank Status Study
21 Terminated High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy
Condition: Breast Cancer
Intervention: Biological: esterified estrogens
22 Active, not recruiting Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Letrozole
23 Recruiting DETECT IV - A Multicenter Single Arm Phase II Study to Investigate Clinical Efficacy of Everolimus in Combination With Endocrine Therapy in Postmenopausal Patients With Hormone-receptor+ve, HER2-ve MBC and Persisting HER2-ve CTCs
Conditions: HER2-negative Und Hormone-receptor Positive Metastatic Breast Cancer;   HER2-negative Circulating Tumor Cells;   Postmenopausal Female Patients
Intervention: Drug: Everolimus in combination with standard endocrine therapy
24 Active, not recruiting Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Conditions: Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   Progesterone Receptor-positive Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIB Breast Cancer
Interventions: Drug: tamoxifen citrate;   Drug: anastrozole;   Drug: letrozole;   Drug: exemestane;   Radiation: radiation therapy;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment
25 Completed
Has Results
Early Menopause Hormone Treatment and Cognition
Condition: Menopausal Syndrome
Interventions: Drug: Estradiol (E2);   Drug: Progesterone (P10) x90;   Drug: Progesterone (P10) x10
26 Completed Views and Attitudes of Oncologists and Geriatricians on the Use of Chemotherapy and Hormone Therapy in Treating Older and/or Frail Women With Breast Cancer
Condition: Breast Cancer
Intervention: Other: survey administration
27 Active, not recruiting Preoperative Hormone Therapy for Postmenopausal Women With ER+ Clinical Stage T2-4 Tumors
Conditions: Breast Cancer;   Stage II Breast Cancer;   Stage III Breast Cancer
Intervention: Drug: Exemestane
28 Unknown  Comparison of Hormonal Therapy: Mediating Hot Flashes Tapering Regimens for Mediating Hot Flashes
Conditions: Hot Flashes;   Night Sweats
Intervention: Drug: Estradiol
29 Completed Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections
Conditions: Atherosclerosis;   Chlamydia Infections;   Cytomegalovirus Infections;   Pneumonia, Bacterial;   Postmenopause
Intervention: Drug: Estrogen therapy
30 Unknown  Paclitaxel, Cyclophosphamide, and Doxorubicin Followed by Autologous Dendritic Cells and Surgery With or Without Radiation Therapy and/or Hormone Therapy in Treating Women With Stage II or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Biological: therapeutic autologous dendritic cells;   Drug: aromatase inhibition therapy;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: paclitaxel;   Drug: tamoxifen citrate;   Genetic: gene expression analysis;   Genetic: protein expression analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: immunoenzyme technique;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Procedure: adjuvant therapy;   Procedure: biopsy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy
31 Completed Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
Conditions: Recurrent Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: lapatinib ditosylate;   Drug: fulvestrant;   Other: placebo;   Other: laboratory biomarker analysis
32 Completed Comparison of Vascular Findings Between Symptomatic and Asymptomatic Postmenopausal Women Before and During Hormone Therapy (HRT)
Conditions: Postmenopausal Vasomotor Symptoms;   Cardiovascular Disease
Interventions: Drug: 17-b-estradiol;   Drug: 17-b-estradiol + medroxyprogeterone acetate;   Drug: 17-b-estradiol hemihydrate;   Drug: placebo pill + gel
33 Withdrawn Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer
Conditions: Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Drug: exemestane;   Procedure: adjuvant therapy;   Procedure: aromatase inhibition;   Procedure: conventional surgery;   Procedure: endocrine therapy;   Procedure: hormone therapy;   Procedure: neoadjuvant therapy;   Procedure: surgery
34 Active, not recruiting LINE: Treatment Patterns in postmenopausaL Women With Hormone Receptor Positive Breast Cancer
Condition: Local Advanced or Metastatic Postmenopausal Breast Cancer
Intervention:
35 Active, not recruiting Extended Endocrine Therapy for Premenopausal Women With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: leuprolide;   Drug: letrozole;   Drug: zoledronic acid
36 Completed Endometriosis : Traditional Medicine vs Hormone Therapy
Conditions: Endometriosis;   Pelvic Pain
Interventions: Procedure: Acupuncture;   Drug: Chinese Products;   Drug: Nafarelin
37 Completed Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: epirubicin hydrochloride;   Drug: tamoxifen citrate;   Drug: toremifene
38 Withdrawn Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer
Conditions: Stage IV Breast Cancer;   Recurrent Breast Cancer
Interventions: Drug: tamoxifen;   Drug: trastuzumab;   Procedure: antibody therapy;   Procedure: antiestrogen therapy;   Procedure: biological response modifier therapy;   Procedure: drug resistance inhibition;   Procedure: endocrine therapy;   Procedure: hormone therapy;   Procedure: monoclonal antibody therapy
39 Completed
Has Results
Sequencing Of Endocrine Therapy In Post-Menopausal Women With Early Breast Cancer (FAST)
Condition: Post Menopausal Women With Early Breast Cancer
Intervention: Drug: Aromasin  (exemestane)
40 Completed Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer
Condition: Endometrial Cancer
Interventions: Drug: medroxyprogesterone;   Drug: ethinyl estradiol;   Drug: norgestrel;   Other: laboratory biomarker analysis

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years